Offer - Urjas Oil for just ₹ 1 X
Cardivas 6.25 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of High BP. The alternative uses of Cardivas 6.25 Tablet have also been explained below.
The optimal dosage of Cardivas 6.25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Cardivas 6.25 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Cardivas 6.25 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Cardivas 6.25 Tablet is Moderate for pregnant women and Safe for women who are breastfeeding. It is important to know if Cardivas 6.25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Cardivas 6.25 Tablet related warnings section.
Cardivas 6.25 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) as it can result in adverse effects. Other conditions have been mentioned below in the Cardivas 6.25 Tablet contraindications section.
Besides this, Cardivas 6.25 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Cardivas 6.25 Tablet is not safe while driving, and is not addiction.
Cardivas 6.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Cardivas 6.25 Tablet safe for pregnant women?
Cardivas can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Cardivas right away. Take your doctor's advice before taking it again.
Is the use of Cardivas 6.25 Tablet safe during breastfeeding?
Cardivas does not show any harmful effects in lactating women.
What is the effect of Cardivas 6.25 Tablet on the Kidneys?
Cardivas is completely safe for kidneys.
What is the effect of Cardivas 6.25 Tablet on the Liver?
Cardivas is rarely harmful for the liver.
What is the effect of Cardivas 6.25 Tablet on the Heart?
Cardivas has very mild side effects on the heart.
Cardivas 6.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cardivas 6.25 Tablet unless your doctor advises you to do so -
Is this Cardivas 6.25 Tablet habit forming or addictive?
No, you will not get addicted to Cardivas 6.25 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cardivas 6.25 Tablet, you should not drive or work on any heavy machine, as Cardivas 6.25 Tablet can make you drowsy.
Is it safe?
Cardivas 6.25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Cardivas 6.25 Tablet in mental disorders is not effective.
Interaction between Food and Cardivas 6.25 Tablet
Some foods when eaten with Cardivas 6.25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Cardivas 6.25 Tablet
Consult your doctor before consuming alcohol while taking Cardivas 6.25 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)